Drug Profile
Research programme: Parkinson's disease therapies - Zymes
Alternative Names: Co-Q10 - Zymes; Coenzyme Q10 - Zymes; HQO; Ubidecarenone - ZymesLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Zymes
- Class Coenzymes; Vitamins
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Parkinson's-disease in Canada